Quotes Abbott Laboratories Deutsche Boerse AG
Stocks
ABL0
CA0028221046
Medical Equipment, Supplies & Distribution
|
Market Closed -
Deutsche Boerse AG
02:56:02 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 10.70 EUR | 0.00% |
|
0.00% | -20.15% |
| 07:13pm | Trump Disclosed 517 Securities Transactions in August, Including Up to $25 Million Meta Purchase | MT |
| 10-07 | Abbott Introduces Ensure Max Protein 3-In-1 Muscle Support Protein Powder | CI |
Stock exchange
Deutsche Boerse AG
ABL0 10.70 €
0.00%
0
€
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| ABT | 98.49USD | -0.24% | 1.37B $ | ||
CBOE
| ABT | 98.48USD | -0.25% | 17.2M $ | |
|
Tradegate
| ABL | 87.84EUR | -0.41% | 143K € | |
|
London S.E.
| ABT | 100.56USD | +2.78% | 48.57K $ | |
|
Boerse Muenchen
| ABL | 87.83EUR | -0.19% | 39.61K € | |
|
Xetra
| ABL | 86.94EUR | -1.00% | 15.21K € | |
|
CBOE
| ABT | 87.00EUR | -0.34% | 14.96K € | |
|
Borsa Italiana
| 1ABT | 85.98EUR | -0.62% | 12.9K € | |
|
Mexican S.E.
| ABT * | 1,785.05MXN | +1.42% | 252K $ | |
|
Börse Stuttgart
| ABL | 87.72EUR | -0.52% | 5.26K € | |
|
Kazakhstan S.E.
| ABT_KZ | 110.00USD | 0.00% | 110 $ | |
|
Lima
| ABTUS | 100.10USD | 0.00% | 0 $ | |
|
Wiener Boerse
| ABT | 86.98EUR | -0.80% | 0 € | |
|
Swiss Exchange
| ABT | 82.00CHF | -1.20% | 0 CHF | |
|
CBOE
| 88.36EUR | 0.00% | 0 € | ||
|
Santiago S.E.
| ABTCL | 97,823.00CLP | 0.00% | 0 $ | |
|
Deutsche Boerse AG
| ABL | 87.86EUR | -0.27% | 0 € | |
|
Santiago S.E.
| ABT | 100.98USD | 0.00% | 0 $ | |
| ABTT34 | 41.30BRL | -16.98% | 2.85K R$ | ||
| ABT | 39,740.00ARS | -0.25% | 24.36M $ | ||
|
Buenos Aires S.E.
| ABTD | 25.89USD | -0.46% | 3.18K $ | |
| ABL0 | 10.70EUR | 0.00% | 0 € | ||
|
Toronto S.E.
| ABT | 17.20CAD | -0.29% | 118K $ |
Quotes 5-day view: Abbott Laboratories
Delayed Quote Deutsche Boerse AG
| 2026-10-02 | 2026-10-05 | 2026-10-06 | 2026-10-07 | 2026-10-08 | |
|---|---|---|---|---|---|
| Last | €10.70 | €10.60 | €10.90 | €10.70 | €10.70 |
| Change | 0.00% | -0.93% | +2.83% | -1.83% | 0.00% |
Performance
| Current month | -1.83% | ||
| 1 month | -9.32% | ||
| 3 months | +3.88% | ||
| 6 months | -5.31% | ||
| Current year | -20.15% | ||
| 1 year | -26.71% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (EUR)
170,840,742,814
Market Cap (USD)
170,840,742,814
Net sales (USD)
44,328,000,000
Number of employees
115,000
Sales / Employee (USD)
385,461
Free-Float
86.16%
Free-Float capitalization (EUR)
190,354,598,918
Free-Float capitalization (USD)
169,986,656,833
Indicators
Moving average 5 days
10.72
Moving average 20 days
11.01
Moving average 50 days
11.55
Moving average 100 days
10.79
Price spread / (MMA5)
+0.19%
Price spread / (MMA20)
+2.90%
Price spread / (MMA50)
+7.91%
Price spread / (MMA100)
+0.85%
RSI 9 days
35.99
RSI 14 days
37.43
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | -26.71% | - | 171B | |
| -0.24% | +1.86% | -26.65% | +1.66% | 171B | |
| +2.62% | +1.52% | -10.34% | +15.28% | 109B | |
| +0.57% | +1.47% | -26.20% | +4.18% | 106B | |
| -2.49% | -1.11% | -48.69% | -12.84% | 75.43B | |
| +1.29% | +3.73% | +3.46% | +74.79% | 60.54B | |
| -0.54% | +2.94% | +11.92% | +64.78% | 53.16B | |
| +1.44% | +2.63% | -5.76% | -30.36% | 49.07B | |
| +1.28% | -0.89% | -18.54% | +15.06% | 39.92B | |
| +0.13% | -2.11% | +24.54% | +1.43% | 31.81B | |
| Average | +0.41% | +1.74% | -12.30% | +14.89% | 86.66B | |
| Weighted average by Cap. | +0.34% | +1.83% | -18.56% | +12.30% |
Historical Quotes: Abbott Laboratories
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 10.6 |  | 10.9 |
| 1 month | 10.6 | | 11.4 |
| Current year | 9.2 | | 14.8 |
| 1 year | 9.2 | | 14.8 |
| 3 years | 9.2 | | 16 |
| 5 years | 9.2 | | 16 |
| 10 years | 9.2 | | 16 |
Monthly variations
Annual variations
| 2026 | -20.15% | ||
| 2025 | -10.60% |
- Stock Market
- Stocks
- ABT Stock
- ABL0 Stock
- Quotes Abbott Laboratories
Select your edition
All financial news and data tailored to specific country editions
